Woman Learns She Has Same Disease that Took the Lives of Her Mom and Sister, Leaving Teenage Son 'Absolutely Devastated'
Holly Turner's doctors initially thought her tremors were due to stress, but they were symptoms of ALS, which also took the ...
Interesting Engineering on MSN17h
Non-invasive brain headset gives back power of speech to ALS patients
A non-invasive and artificial intelligence (AI) powered brain-computer interface (BCI) device developed by US-based ...
Study Finds on MSN3d
Researchers uncover serious flaw in promising Alzheimer’s blood tests
New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
ALS News Today1d
Finding my place as someone with slow ALS progression
Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...
ALS drug failures and why COYA 302 is different
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
StudyFinds on MSN10d
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
ALS News Today18h
Denali halts extension of DNL343 arm in HEALEY ALS trial
Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
EurekAlert!8d
Diagnosing Alzheimer’s disease using blood tests: p-tau biomarkers not as disease-specific as previously thought
The early diagnosis of Alzheimer’s disease (AD) through the detection of p-tau proteins in the blood is less disease-specific ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
Fierce Biotech7d
Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension
Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...
University of Denver8d
Researcher Spotlight: Sunil Kumar
This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...